Multiples measured against the stock's own five-year history
Below its usual level · 30th percentile, 5-year average -3.6x
Around its usual level · 55th percentile, 5-year average 2.1x
#2773 of 5317 stocks by PB (1 = cheapest)
Around its usual level · 53rd percentile, 5-year average 9.4x
#4012 of 5146 stocks by PS (1 = cheapest)
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 1.84 | – | 2.12 | 55% (pricier than usual) | #2773 of 5317 (1 = cheapest) |
| PE | -2.29 | -3.28 | -3.60 | 30% (cheaper than usual) | – |
| PS | 5.83 | 8.35 | 9.39 | 53% (pricier than usual) | #4012 of 5146 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on DNA.